DGMT service contract on PacBio Revio sequencer
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 811219 Other Electronic and Precision Equipment Repair and Maintenance
- Points of contact
-
- NCTR Acquisition Liaison nctr.acquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is seeking a maintenance and support service contract for a PacBio Revio next-generation sequencing (NGS) instrument. The contract will cover diagnostic genomic management technology (DGMT) services on the base instrument plus up to three option periods. The solicitation is estimated to be released on January 1, 2026, with an anticipated award date of April 1, 2026.
The estimated contract value ranges from $250,000 to $700,000, with the work classified under NAICS code 811219 for electronic and precision equipment repair and maintenance. Interested contractors should direct inquiries to the FDA's National Center for Toxicological Research acquisitions team at nctr.acquisitions@fda.hhs.gov. This is a new requirement with no set-aside restrictions, allowing full competition among qualified vendors.
Forecast text
DGMT service contract on PacBio Revio NGS instrument base plus up to 3 option periods
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast